Quarterly report [Sections 13 or 15(d)]

Statements of Operations (Unaudited)

v3.25.3
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ (333) $ 57 $ (1,199) $ 8,221
Asset impairment 0 0 0 2,649
General and administrative 957 1,400 2,961 4,358
Total operating expenses 624 1,457 1,762 15,228
Loss from operations (624) (1,457) (1,762) (15,228)
Other income        
Other income 0 0 0 314
Interest income, net 156 47 379 114
Total other income 156 47 379 428
Net Loss $ (468) $ (1,410) $ (1,383) $ (14,800)
Net loss per Class A common and common shares outstanding, basic $ (0.07) $ (1.96) $ (0.32) $ (32.18)
Net loss per Class A common and common shares outstanding, diluted $ (0.07) $ (1.96) $ (0.32) $ (32.18)
Weighted average number of Class A common and common shares outstanding, basic 6,241,658 720,911 4,387,035 459,856
Weighted average number of Class A common and common shares outstanding, diluted 6,241,658 720,911 4,387,035 459,856